Topical formulations of Aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration.
Authors
Bonelli F, Demirsoy I, Lasagni Vitar RM, Fonteyne P, Ferrari G
Abstract
To test long-term ocular toxicity and analgesic/anti-inflammatory efficacy of two novel ocular formulations of neurokinin 1 receptor (NK1R) antagonist Aprepitant.
This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the IASP Privacy Policy. By closing this banner, you agree to the use of cookies.Agree
